The in-vitro colorectal cancer screening tests market size has the potential to grow by USD 270.96 million during 2021-2025, and the market’s growth momentum will accelerate at a CAGR of 5.60%.
This report provides a detailed analysis of the market by end-user (hospitals, clinical diagnostic laboratories, and others), geography (North America, Europe, Asia, and ROW), and key vendors.
Market Overview
Browse TOC and LoE with selected illustrations and example pages of In-vitro Colorectal Cancer Screening Tests Market
Market Competitive Analysis
The report analyzes the market’s competitive landscape and offers information on several market vendors, including:
- Abbott Laboratories
- Danaher Corp.
- Epigenomics AG
- Exact Sciences Corp.
- Immunostics Inc.
- NOVIGENIX SA
- QIAGEN NV
- Quest Diagnostics Inc.
- R-Biopharm AG
- Sysmex Corp.
The in-vitro colorectal cancer screening tests market is fragmented and the vendors are deploying growth strategies such as R&D to compete in the market. Click here to uncover other successful business strategies deployed by the vendors.
The market players also significantly leverage external market drivers such as the rising occurrence of colorectal cancer to achieve growth opportunities. However, factors such as lack of manpower will challenge the growth of the market participants. To make the most of the opportunities and recover from post COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.
Download a free sample of the in-vitro colorectal cancer screening tests market forecast report for insights on complete key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies.
This in-vitro colorectal cancer screening tests market analysis report also provides detailed information on the upcoming trends and challenges that will influence market growth. This will help companies create strategies to make the most of future growth opportunities.
In-vitro Colorectal Cancer Screening Tests Market: Key Drivers and Trend
|
|
|
Grab your Free Sample now to unlock further information on other key market drivers
In-vitro Colorectal Cancer Screening Tests Market: Segmentation by Geography
For more insights on the market share of various regions Request for a FREE sample now!
39% of the market’s growth will originate from North America during the forecast period. The US is a key market for in-vitro colorectal cancer screening tests in North America. However, market growth in this region will be slower than the growth of the market in Asia and Europe.
The significant investments in healthcare research and testing will facilitate the in-vitro colorectal cancer screening tests market growth in North America over the forecast period. To garner further competitive intelligence and regional opportunities in store for vendors, view our sample report.
In-vitro Colorectal Cancer Screening Tests Market: Segmentation by End-user
Request for a FREE sample and Get more information on the market contribution of various segments
Hospitals have the advanced medical infrastructure to cater to the needs of people. Hospitals are increasingly focusing on screening, monitoring, and diagnosis of colorectal cancer as an outpatient procedure. Most importantly, hospital settings provide opportunities for patients who do not have access to facilities such as clinical diagnostic laboratories. Globally, most hospitals have tie-ups with R&D centers and research institutes, which can increase the development and efficiency of screening tests in the market.
Fetch actionable market insights on post COVID-19 impact on each segment. This report provides an accurate prediction of the contribution of all the segments to the growth of the in-vitro colorectal cancer screening tests market size.
In-vitro Colorectal Cancer Screening Tests Market: Key Highlights of the Report for 2021-2025
- CAGR of the market during the forecast period 2021-2025
- Detailed information on factors that will drive in-vitro colorectal cancer screening tests market growth during the next five years
- Precise estimation of the in-vitro colorectal cancer screening tests market size and its contribution to the parent market
- Accurate predictions on upcoming trends and changes in consumer behavior
- The growth of the in-vitro colorectal cancer screening tests industry across North America, Europe, Asia, and ROW
- A thorough analysis of the market’s competitive landscape and detailed information on vendors
- Comprehensive details of factors that will challenge the growth of in-vitro colorectal cancer screening tests market vendors
We can help! Our analysts can customize this report to meet your requirements. Get in touch
|
In-vitro Colorectal Cancer Screening Tests Market Scope |
|
|
Report Coverage |
Details |
|
Page number |
120 |
|
Base year |
2020 |
|
Forecast period |
2021-2025 |
|
Growth momentum & CAGR |
Accelerate at a CAGR of 6% |
|
Market growth 2021-2025 |
$ 270.96 million |
|
Market structure |
Fragmented |
|
YoY growth (%) |
5.19 |
|
Regional analysis |
North America, Europe, Asia, and ROW |
|
Performing market contribution |
North America at 39% |
|
Key consumer countries |
US, Germany, Japan, UK, and France |
|
Competitive landscape |
Leading companies, competitive strategies, consumer engagement scope |
|
Companies profiled |
Abbott Laboratories, Danaher Corp., Epigenomics AG, Exact Sciences Corp., Immunostics Inc., NOVIGENIX SA, QIAGEN NV, Quest Diagnostics Inc., R-Biopharm AG, and Sysmex Corp. |
|
Market Dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and future consumer dynamics, market condition analysis for forecast period, |
|
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |